// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

INCREASED PULSE PRESSURE ASSOCIATED WITH A DECLINE IN BRAIN STRUCTURE AND FUNCTION ( THE SOUTHALL AND BRENT REVISITED (SABRE) STUDY )

Li Han Wong, B - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

White matter hyperintensities

N/A

AMYLOID BETA 1–40 AND ITS UPSTREAM REGULATORY PATHWAY BACE1-AS LONG NONCODING RNA/BACE1 ARE ASSOCIATED WITH PRESENCE AND SEVERITY OF HUMAN ATHEROSCLEROTIC DISEASE

Gergiopoulos, G - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

INVESTIGATION OF PLACENTAL PROTEOME OF PREGNANT STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS

Samji, S.M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ASSOCIATIONS OF EARLY BLOOD PRESSURE CONTROL AND OUTCOME IN THROMBOLYSIS-ELIGIBLE ACUTE ISCHAEMIC STROKE IN THE ENHANCED CONTROL OF HYPERTENSION AND THROMBOLYSIS STROKE STUDY

Chalmers, J - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Activase I.V.

BLOOD PRESSURE AND RISK OF VENOUS THROMBOEMBOLISM ( A LARGE-SCALE PROSPECTIVE COHORT ANALYSIS AND A MENDELIAN RANDOMISATION STUDY )

Nazarzadeh, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

SUBGROUP ANALYSIS IN THE GLOBAL SYMPLICITY REGISTRY ( 3-YEAR SAFETY AND EFFICACY )

Mahfoud, F - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Type 2 diabetes mellitus

N/A

SODIUM AND POTASSIUM INTAKE IN ADULTS IN PODGORICA, MONTENEGRO

DElia, L - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

IMPACT OF INTER-ARM BLOOD PRESSURE DIFFERENCE ON CARDIOVASCULAR RISK ESTIMATION IN PRIMARY CARE

Mcdonagh, S - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

POST-STROKE WHITE COAT HYPERTENSION/EFFECT IS ASSOCIATED WITH GREATER ARTERIAL STIFFNESS

Saunders, A - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

White coat hypertension

N/A

ARTERIAL STIFFNESS AND REMODELING FROM LARGE TO SMALL ARTERIES IN PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION ( EVIDENCE FOR A SYSTEMIC SUBCLINICAL INVOLVEMENT )

Bruno, R.M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Spontaneous coronary artery dissection

N/A

A PERSONALISED, CLINICAL PHARMACOLOGICAL APPROACH TO ACUTE AND SUBACUTE MANAGEMENT OF VERY HIGH BLOOD PRESSURE (BP) IN SECONDARY CARE

Janmohamed, A - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

LEFT ATRIAL SIZE AND FUNCTION ASSESSMENT BY CARDIAC MAGNETIC RESONANCE IN THALASSEMIA MAJOR PATIENTS WITH DIFFERENT IRON OVERLOAD CONDITIONS

Torlasco, C - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Beta-thalassemia

N/A

TRANSLATING SIGNALS FROM GENOME-WIDE ASSOCIATION STUDIES INTO BIOLOGICAL MECHANISMS OF HYPERTENSION THROUGH KIDNEY -OMICS

Jiang, X - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal disease

N/A

WHITE COAT HYPERTENSION/EFFECT IS ASSOCIATED WITH CEREBRAL SMALL VESSEL DISEASE

Drazich, E - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cerebral small vessel disease

N/A

ANGIOTENSIN II TYPE 1 RECEPTOR AUTOANTIBODIES ( CAUSE OR CONSEQUENCE OF HUMAN PRIMARY ALDOSTERONISM? )

Piazza, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Primary aldosteronism

Angiotensin II

FREQUENCY AND DETERMINANTS OF AMBULATORY VERSUS HOME BLOOD PRESSURE DIFFERENCE AND THEIR DIAGNOSTIC DISAGREEMENT

Ntineri, A - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

ALTERED CENTRAL HAEMODYNAMIC PARAMETERS DERIVED FROM RESERVOIR PRESSURE ANALYSIS ( ASSOCIATION WITH BIOMARKERS OF TARGET ORGAN DAMAGE IN OLDER ADULTS )

Aizawa, K - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Whole genome sequencing and imputation in inflammatory bowel disease identifies 26 novel loci and offers therapeutically-relevant mechanistic insights

L. Moutsianas - European Crohn’s and Colitis Organisation (ECCO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

Epigenetic biomarkers to detect ulcerative colitis-associated neoplasia: results from phase I of the ENDCAP-C study

T. Iqbal - European Crohn’s and Colitis Organisation (ECCO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn's disease

L. Le Bourhis - European Crohn’s and Colitis Organisation (ECCO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved